Skip to main content

Advertisement

Log in

Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The term “acute transverse myelitis (ATM)” comprises various non-traumatic disorders that eventually can be associated with a focal myelopathy. Patients characteristically present with an acutely occurring paraparesis/plegia and require a comprehensive and timely diagnostic work up for the initiation of an appropriate treatment. We present a case of a 36-year-old female patient with a rare genetic disorder (ANE1: Acute Necrotizing Encephalopathy due to a RANBP2 mutation) who presented with an acute quadriplegia. Following an acute pulmonal infection, she rapidly (< 24 h) developed a severe quadriplegia (total motor score 38) with some facial sensory symptoms (perioral hypoesthesia). Magnetic resonance imaging (MRI) revealed a combination of longitudinal extensive transverse myelitis and symmetrical thalamic lesions. A work-up for infectious and systemic diseases was negative; specifically, no findings related to multiple sclerosis, neuromyelitis optica or vascular disorders. After empirical high dose steroid treatment and rehabilitation therapy, the patient gained almost normal gait and upper limb function. She was found to carry an autosomal-dominant missense mutation in the RANBP2 gene predisposing for ANE. Gene segregation was confirmed in other family members that had been affected by other episodes of acute steroid-responsive encephalopathies. We propose that a redefined diagnostic workup of ATM might include ANE1, as the frequency of this rare disorder might be underestimated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Miller FG, Ross AG (1931) Acute transverse myelitis complicating measles. Can Med Assoc J 25(6):709–710

    CAS  PubMed  Google Scholar 

  2. Ropper AH, Poskanzer DC (1978) The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 4(1):51–59

    Article  CAS  PubMed  Google Scholar 

  3. Berman M, Feldman S, Alter S et al (1981) Acute transverse myelitis: incidence and etiologic considerations. Neurology 31:966–971

    Article  CAS  PubMed  Google Scholar 

  4. Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50:532–535

    Article  CAS  PubMed  Google Scholar 

  5. Transverse Myelitis Consortium Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505

    Article  Google Scholar 

  6. de Seze J, Stojkovic T, Breteau G et al (2001) Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 124:1509–1521

    Article  PubMed  Google Scholar 

  7. Frohman EM, Wingerchuk DM (2010) Transverse myelitis. N Engl J Med 363:564–572

    Article  CAS  PubMed  Google Scholar 

  8. Schmalstieg WF, Weinshenker BG (2010) Approach to acute or subacute myelopathy. Neurology 75:2–8

    Article  Google Scholar 

  9. Neilson DE, Adams MD, Orr C et al (2009) Infection-triggered familial or recurrent cases of Acute Necrotizing Encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet 84:44–51

    Article  CAS  PubMed  Google Scholar 

  10. Krishnan C, Kaplin AI, Deshpande DM et al (2004) Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci 9:1483–1499

    Article  CAS  PubMed  Google Scholar 

  11. Scott TF, Kassab SL, Singh S (2005) Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 11:373–377

    Article  PubMed  Google Scholar 

  12. Young J, Quinn S, Hurrel M et al (2009) Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler 15:1295–1302

    Article  PubMed  Google Scholar 

  13. Klein NP, Ray P, Carpenter D et al (2010) Rates of autoimmune diseases in Kaiser Permanent for use in vaccine adverse event safety studies. Vaccine 28:1062–1068

    Article  PubMed  Google Scholar 

  14. Pidcock FS, Krishnan C, Crawford TO et al (2007) Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 68:1474–1480

    Article  CAS  PubMed  Google Scholar 

  15. Banwel B, Kennedy J, Sadovnick D et al (2009) Incidence of acquired demyelination of the CNS in Canadian children. Neurology 72:232–239

    Article  Google Scholar 

  16. de Seze J, Lanctin C, Lebrun C et al (2005) Ideopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65:1950–1953

    Article  PubMed  Google Scholar 

  17. Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic Criteria for multiple sclerosis: 2010 Revision of the McDonald criteria. Ann Neurol 69:292–302

    Article  PubMed  Google Scholar 

  18. Borchers AT, Gershwin ME (2012) Transverse myelitis. Autoimmun Rev 11:231–248

    Article  CAS  PubMed  Google Scholar 

  19. Scott TF (2007) Nosology of ideopathic transverse myelitis syndromes. Acta Neurol Scand 115:371–376

    Article  PubMed  Google Scholar 

  20. Sellner J, Luthi N, Buhler R et al (2008) Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis. Eur J Neurol 15:398–405

    Article  CAS  PubMed  Google Scholar 

  21. Cordonnier C, de Seze J, Breteau G et al (2003) Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 250:1442–1452

    Article  Google Scholar 

  22. Ford B, Tampieri D, Francis G (1992) Long-term follow-up of acute partial transverse myelopathy. Neurology 42:250–252

    Article  CAS  PubMed  Google Scholar 

  23. Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485–1489

    Article  CAS  PubMed  Google Scholar 

  24. Weinshenker BG, Wingerchuk DM, Vukusic S et al (2006) Neuromyelitis optica IgG predicts relaps after longitudinally extensive transverse myelitis. Ann Neurol 59(3):566–569

    Article  CAS  PubMed  Google Scholar 

  25. Martiello M, Lennon VA, Jacob A et al (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70(23):2194–2200

    Article  Google Scholar 

  26. Coulter I, Huda S, Baborie A et al (2012) Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behcet’s disease responding to infliximab. J Spinal Cord Med 35(2):122–124

    Article  PubMed  Google Scholar 

  27. Eckstein C, Saidha S, Levy M (2012) A differential diagnosis of central nervous system demyelinisation: beyond multiple sclerosis. J Neurol 259:801–816

    Article  PubMed  Google Scholar 

  28. Haan J, Haupts M, Uhlenbrock D (1987) Magnetic resonance imaging (MRI), cranial computerized tomography (CCT), evoked potentials and cerebrospinal fluid (CSF) analysis in five patients with funicular myelosis. Neurosurg Rev 10(3):209–2011

    Article  CAS  PubMed  Google Scholar 

  29. Habek M, Adamec I, Pavlisa G et al (2012) Diagnostic approach of patients with longitudinally extensive transverse myelitis. Acta Neurol Belg 112(1):39–43

    Article  PubMed  Google Scholar 

  30. Kincaid O, Lipton HL (2006) Viral myelitis: an update. Curr Neurol Neurosci Rep 6(6):469–474

    Article  PubMed  Google Scholar 

  31. Rigamonti A, Usai S, Ciusani E et al (2005) Atypical transverse myelitis due to cytomegalovirus in a immunocompetent patient. Neurol Sci 26:351–354

    Article  CAS  PubMed  Google Scholar 

  32. Tyler KL, Gross RA, Cascino GD (1986) Unusual viral causes of transverse myelitis: hepatitis A virus and cytomegalovirus. Neurology 36:855–858

    Article  CAS  PubMed  Google Scholar 

  33. Yylmaz S, Koseolu HK, Yucel E (2007) Transverse myelitis caused by varicella zoster: case reports. Braz Infect Dis 11:179–181

    Article  Google Scholar 

  34. Karunarathne S, Govindapala D, Udayakumara Y et al (2012) Cytomegalovirus associated transverse myelitis in an immunocompetent host with DNA detection in cerebrospinal fluid: a case report. BMC Res Notes 5(1):364 [Epub ahead of print]

    Article  PubMed  Google Scholar 

  35. Sanefuji M, Ohga S, Kira R et al (2008) Epstein-Barr virus-associated meningoencephalolmyelitis: intrathecal reactivation of the virus in an immunocompetent child. J Child Neurol 23(9):1072–1077

    Article  PubMed  Google Scholar 

  36. Bhat A, Naguwa S, Cheema G et al (2010) The epidemiology of transverse myelitis. Autoimmun Rev 9(5):A395–A399

    Article  PubMed  Google Scholar 

  37. Krishnan C, Kaplin AI, Graber JS et al (2005) Recurrent transverse myelitis following neurobrucellosis: immunologic features and beneficial response to immunosuppression. J Neurovirol 11(2):225–231

    Article  CAS  PubMed  Google Scholar 

  38. Shakir RA, Al-Din AS, Araj GF et al (1987) Clinical categories of neurobrucellosis. A report of 19 cases. Brain 110(1):213–223

    Article  PubMed  Google Scholar 

  39. Crook T, Bannister B (1996) Acute transverse myelitis associated with Chlamydia psittaci infection. J Infect 32(2):151–152

    Article  CAS  PubMed  Google Scholar 

  40. Bigi S, Aebi C, Nauer C et al (2010) Acute transverse myelitis in Lyme neuroborreliosis. Infection 38:413–416

    Article  CAS  PubMed  Google Scholar 

  41. Kayal AK, Goswami M, Das M et al (2011) Clinical spectrum of neurosyphilis in North East India. Neurol India 59(3):344–350

    Article  PubMed  Google Scholar 

  42. Garg RK, Sharma R, Kar AM, Kushawa RA et al (2010) Neurological complications of miliary tuberculosis. Clin Neurol Neurosurg 112(3):188–192

    Article  PubMed  Google Scholar 

  43. Alper G, Petropoulou P, Fitz CR et al (2011) Ideopathic acute transverse myelitis in children: an analysis and discussion of MRI findings. Mult Scler 17(1):74–80

    Article  PubMed  Google Scholar 

  44. Al Deeb SM, Yaqub BA, Bruyn GW et al (1997) Acute transverse myelitis—a localized form of post-infectious encephalomyelitis. Brain 120:1115–1122

    Article  PubMed  Google Scholar 

  45. Young NP, Weinshenker BG, Lucchinetti CF (2008) Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 28(1):84–94

    Article  PubMed  Google Scholar 

  46. Miller DH, Weinshenker BG, Filippi M et al (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14(9):1157–1174

    Article  CAS  PubMed  Google Scholar 

  47. Jacob A, Weinshenker BG (2008) An approach to the diagnosis of acute transverse myelitis. Semin Neurol 28(1):105–120

    Article  PubMed  Google Scholar 

  48. Keegan M, Pittock S, Lennon V (2008) Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol 63(4):531–534

    Article  PubMed  Google Scholar 

  49. Eiben RM, Dooley JP, Stowes SM et al (1965) Subacute necrotizing encephalopathy in infancy. Neurology 15:293 (Abstract)

    Google Scholar 

  50. Mizuguchi M (1997) Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev 19:81–92

    Article  CAS  PubMed  Google Scholar 

  51. Mastroyianni SD, Gionnis D, Voudris K et al (2006) Acute necrotizing encephylopathy of childhood in non-Asian patients: report of three cases and literature review. Child Neurol 21:872–879

    Article  Google Scholar 

  52. Campistol J, Gassio R, Pineda M et al (1998) Acute necrotizing encephalopathy of childhood (infantile bilateral thalamic necrosis): two non-Japanese cases. Dev Med Child Neurol 40:771–774

    Article  CAS  PubMed  Google Scholar 

  53. Saji N, Yamamoto N, Yoda J et al (2006) Adult case of acute encephalopathy associated with bilateral thalamic lesions and peripheral neuropathy. No To Shinkei 58:1009–1014 (article in Japanese)

    PubMed  Google Scholar 

  54. Miyata E (2002) An adult case of acute necrotizing encephalopathy. No To Shinkei 54:354–355 (article in Japanese)

    PubMed  Google Scholar 

  55. Nakamura Y, Miura K, Yamada I et al (2000) A novel adult case of acute necrotizing encephalopathy of childhood with bilateral symmetric thalamic lesions. Rinsho Shinkeigaku 40:827–831 (article in Japanese)

    CAS  PubMed  Google Scholar 

  56. Fasano A, Natoli GF, Cianfoni A et al (2007) Acute necrotizing encephalopathy. A relapsing case in an European adult. J Neuro Neurosurg Psychiatry 79(2):227–228

    Article  Google Scholar 

  57. Kato H, Hasegawa H, Iijima M et al (2007) Brain magnetic resonance imaging of an adult case of acute necrotizing encephalopathy. J Neurol 254:1135–1137

    Article  PubMed  Google Scholar 

  58. Mizuguchi M, Yamanouchi H, Ichiyama T et al (2007) Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115:45–56

    Article  CAS  PubMed  Google Scholar 

  59. Mizoguchi M, Hayashi M, Nakano I et al (2002) Concentric structure of thalamic lesions in acute necrotizing encephalopathy. Neuroradiology 44:489–493

    Article  Google Scholar 

  60. Kansagra SM, Gallentine WB (2011) Cytokine storm of acute necrotizing encephalopathy. Ped Neurol 45(6):400–402

    Article  Google Scholar 

  61. Okumura A, Mizoguchi M, Kidokoro H et al (2009) Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev 31(3):221–227

    Article  PubMed  Google Scholar 

  62. Neilson DE, Eiben RM, Winiewski S et al (2003) Autosomal dominant acute necrotizing encephalopathy. Neurology 61:226–230

    Article  CAS  PubMed  Google Scholar 

  63. Neilson DE, Feiler HS, Wilhelmsen KC et al (2004) Autosomal dominant acute necrotizing encephalopathy maps to 2q12.1-2q. Ann Neurol 55:291–294

    Article  CAS  PubMed  Google Scholar 

  64. Bergamino L, Capra V, Biancheri R et al (2012) Immunomodulatory therapy in recurrent acute necrotizing encephalopathy ANE1: is it useful? Brain Dev 35(5):384–391

    Article  Google Scholar 

  65. Cho KI, Cai Y, Yi H et al (2007) Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and funktion. Traffic 8:1722–1735

    Article  CAS  PubMed  Google Scholar 

  66. Aslanukov A, Bhowmick R, Guruju M et al (2006) RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficites in glucose metabolism. PLoS Genet 2(10):e177

    Article  PubMed  Google Scholar 

  67. Belay ED, Bresee JS, Holman RC et al (1999) Reye’s Syndrom in the United States from 1981 trough 1997. N Eng J Med 340(18):1377–1382

    Article  CAS  Google Scholar 

  68. Neri M, Cantatore S, Pomara I et al (2011) Immunohistochemichal expression of proinflammatory cytokines Il-1beta, Il-6, TNF-alpha and involvement of COX-2, quantitatively confirmed by Western blot analysis. Wernicke’s encephalopathy. Pathol Res Pract 207(10):652–658

    Article  CAS  PubMed  Google Scholar 

  69. Brown GK, Squier MV (1996) Neuropathology and pathogenesis of mitochondrial diseases. J Inher Metab Dis 19(4):553–572

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the patient for her agreement into publishing her data and for her great support, especially in the establishment of her pedigree. The study was funded by the Swiss National Science Foundation and by the Clinical Research Priority Program Neuro-Rehab of the University of Zurich, Switzerland.

Conflicts of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katharina Wolf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolf, K., Schmitt-Mechelke, T., Kollias, S. et al. Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis. J Neurol 260, 1545–1553 (2013). https://doi.org/10.1007/s00415-012-6825-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-012-6825-7

Keywords

Navigation